This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Well Characterized Biologics & Biological Assays
Well Characterized Biologics & Biological Assays is now part of BioProcess International
September 23-26, 2024Hynes Convention Center in Boston, USA

Karl Bertram
Managing Director at ATEM Structural Discovery


Karl holds a PhD in biochemistry and structural biology and has an extensive scientific background in advanced cryo-EM technology. As the co-founder and managing director of ATEM Structural Discovery, Karl currently leads a rapidly growing team of experienced scientific and technical staff to operate and constantly advance ATEM’s cryo-EM technology platform. Karl obtained his PhD at the Max Planck Institute for Biophysical Chemistry in Göttingen (Germany), where he significantly contributed towards solving the first high-resolution 3D structures of the human spliceosome. During his earlier academic career, he obtained a Master of Science degree in Biochemistry from the Ludwig Maximilian University (LMU) Munich and spent time for a research visit at the Rockefeller University in New York City.

Agenda Sessions

  • Advanced cryo-EM solutions for the characterization of biologic drugs